Jean Bousquet to Biological Products
This is a "connection" page, showing publications Jean Bousquet has written about Biological Products.
Connection Strength
0.404
-
Care pathways for the selection of a biologic in severe asthma. Eur Respir J. 2017 12; 50(6).
Score: 0.244
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774.
Score: 0.075
-
Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma. Respir Med. 2019 04; 150:51-62.
Score: 0.066
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper. Allergy. 2021 03; 76(3):677-688.
Score: 0.019